Acute FEV1 and FVC responses to bronchodilators decline significantly over time in COPD patients , whether expressed as absolute , relative or % predicted changes , potentially impacting on the clinical responses to bronchodilator therapy as well as on the annual rate of decline in post-bronchodilator lung function .